Dyslipidemia of insulin resistance syndrome explained; need for treatment to reduce risk emphasized.

Henry N. Ginsberg

Dyslipidemia of insulin resistance syndrome explained; need for treatment to reduce risk emphasized.

Vagelos College of Physicians and Surgeons

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	7
Number of pages	1
Journal	American Journal of Managed Care
Volume	Suppl
Publication status	Published - Jan 2002

ASJC Scopus Subject Areas

Health Policy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Ginsberg, H. N. (2002). Dyslipidemia of insulin resistance syndrome explained; need for treatment to reduce risk emphasized. American Journal of Managed Care, Suppl, 7.

@article{166576841a894b0ab56fe97019e9ddf4,

title = "Dyslipidemia of insulin resistance syndrome explained; need for treatment to reduce risk emphasized.",

author = "Ginsberg, {Henry N.}",

year = "2002",

month = jan,

language = "English",

volume = "Suppl",

pages = "7",

journal = "American Journal of Managed Care",

issn = "1096-1860",

publisher = "Ascend Media",

}

TY - JOUR

T1 - Dyslipidemia of insulin resistance syndrome explained; need for treatment to reduce risk emphasized.

AU - Ginsberg, Henry N.

PY - 2002/1

Y1 - 2002/1

UR - http://www.scopus.com/inward/record.url?scp=0036371234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036371234&partnerID=8YFLogxK

M3 - Article

C2 - 11833457

AN - SCOPUS:0036371234

SN - 1096-1860

VL - Suppl

SP - 7

JO - American Journal of Managed Care

JF - American Journal of Managed Care

ER -

Dyslipidemia of insulin resistance syndrome explained; need for treatment to reduce risk emphasized.

ASJC Scopus Subject Areas

UN SDGs

Other files and links

Cite this